Although one of the most notable things about our second live MedHeads broadcast was Chris Seper’s selfie stick appearance in honor of #himsselfie, some good opinions on healthcare were also touched on.
Chris and our newest addition to the MedCity team, Neil Versel (who rightfully enjoyed a cold beer during the discussion), had been at the HIMSS health IT conference for the past week. In the segment they, in addition to reporter Stephanie Baum, reflected on the news that came out of the whole experience in Chicago, which some 43,000 people attended.
Throughout the conversation they focused on a number of things that are prominently showing up in the healthcare innovation arena as of late, including: Interoperability, meaningful use, the big focus on patient engagement and what the IBM Watson announcement demonstrates for healthcare moving forward.
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
These will be happening live each Friday at 4:00 p.m. EDT. But watch this week’s broadcast after the fact below:
